Ipca Laboratories has reported results for second quarter ended September 30, 2016.
The company has reported more than four-fold jump in its net profit at Rs 54.95 crore for the quarter under review as compared to Rs 12.34 crore for the same quarter in the previous year. Total income of the company increased by 17.38% at Rs 891.25 crore for the quarter under review as compared Rs 759.28 crore for the corresponding quarter previous year.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
